Delcath Systems Inc. Common Stock is a medical technology company that specializes in the development and commercialization of advanced therapies for cancer treatment. With their innovative Precision Chemo-Immunotherapy platform, the company aims to provide targeted therapy solutions to improve patient outcomes and management of liver and other cancers.
